> Detailanzeige

Vas, Jorge; Modesto, Manuela; Aguilar, Inmaculada; Gonçalo, Camila da Silva; Rivas-Ruiz, Francisco

Efficacy and Safety of Auriculopressure for Primary Care Patients with Chronic Non-Specific Spinal Pain: A Multicentre Randomised Controlled Trial

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Efficacy and Safety of Auriculopressure for Primary Care Patients with Chronic Non-Specific Spinal Pain: A Multicentre Randomised Controlled Trial
  • Beteiligte: Vas, Jorge; Modesto, Manuela; Aguilar, Inmaculada; Gonçalo, Camila da Silva; Rivas-Ruiz, Francisco
  • Erschienen: SAGE Publications, 2014
  • Erschienen in: Acupuncture in Medicine
  • Sprache: Englisch
  • DOI: 10.1136/acupmed-2013-010507
  • ISSN: 0964-5284; 1759-9873
  • Schlagwörter: Neurology (clinical) ; Complementary and alternative medicine ; General Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:sec><jats:title>Background</jats:title><jats:p>Chronic uncomplicated musculoskeletal pain in the spine (cervical, thoracic or lumbar) is highly prevalent and may severely limit the daily activities of those affected by it.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>To evaluate the efficacy and safety of treatment with auriculopressure applied to patients with non-specific spinal pain.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A multicentre randomised controlled trial with two parallel arms (true auriculopressure (TAP) and placebo auriculopressure (PAP)) was performed. The intervention phase lasted 8 weeks and outcomes were measured 1 week after the last intervention (T1) and 6 months after baseline (T2). The primary outcome measure was change in pain intensity according to a 100 mm visual analogue scale (pain VAS) at T1. Secondary outcome measures were the Lattinen index, the McGill Pain Questionnaire and the SF-12 health-related quality of life scale (Spanish version in every case).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>There were 265 participants (TAP group, n=130; PAP group, n=135). Pain was most frequently located in the upper back (55.1%, n=146), followed by the lower back (25.3%, n=67) and the dorsal area (12.5%, n=33). Nineteen patients (7.2%) reported pain affecting the entire spine. There were statistically significant differences between TAP and PAP in the change in the pain VAS at T1 of 10 mm (95% CI 2.8 to 17.3, p=0.007) and in the change in the pain VAS at T2 of 7.2 mm (95% CI 0.02 to 14.3, p=0.049) in favour of TAP. We also observed a statistically significant difference of 3.4 points in the physical component of the SF-12 in favour of TAP at T2 (95% CI 0.45 to 6.3, p=0.024). No severe adverse effects were detected or reported during treatment.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The application of auriculopressure in patients with non-specific spinal pain in primary healthcare is effective and safe, and therefore should be considered for inclusion in the portfolio of primary healthcare services.</jats:p></jats:sec><jats:sec><jats:title>Trial Registration Number</jats:title><jats:p>ISRCTN01897462.</jats:p></jats:sec>